Why the study?
Does syringaldehyde protect against isoproterenol-induced cardiotoxicity in rats?
Population
Rats with isoproterenol (ISO) induced cardiotoxicity model
Comparison
Syringaldehyde at 12.5, 25, and 50 mg/kg… vs Isoproterenol (ISO) administration alone
Design
Preclinical
Key result
Syringaldehyde treatment in rats with isoproterenol-induced cardiotoxicity diminished serum marker enzymes, lipid peroxidation, and protein carbonyl levels while improving myocardial histopathology.
Authors
Loading...
Should not change clinical practice; hypothesis-generating for syringaldehyde in animal cardiotoxicity models.
Does syringaldehyde protect against isoproterenol-induced cardiotoxicity in rats?
Syringaldehyde exhibits concentration-dependent cardioprotective effects against isoproterenol-induced myocardial injury in rats via antioxidant and anti-inflammatory mechanisms.
Shahzad et al. (2018) studied Isoproterenol-induced cardiotoxicity. Syringaldehyde (SYD) vs. Isoproterenol (ISO) alone was evaluated on Marker enzymes, lipid peroxidation, protein carbonyl, and histopathological changes. Syringaldehyde treatment in rats with isoproterenol-induced cardiotoxicity diminished serum marker enzymes, lipid peroxidation, and protein carbonyl levels while improving myocardial histopathology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: